Dr Alex Coundou, the CEO of Calcium, has launched a new research project aimed at exploring how calcium supplementation could help Australia’s population.
The research, which has been launched with the Australian Institute of Sport, was commissioned by the National Health and Medical Research Council and was led by Professor David Wigglesworth from the School of Sport and Exercise Sciences.
“There is an urgent need to reduce obesity rates and reduce the number of deaths that are caused by it,” Professor Wiggelsworth said.
“Calcium is important for the body’s function.
It is a good source of energy, and can be used to fuel growth hormone production.”
Professor Wigglsworth, who has previously conducted studies on the effects of Calca in people with heart disease, said he hoped his new research would help to establish a link between the dietary intake of calcium and the reduction in obesity rates.
“We have found that calcium supplementation may increase the rate of weight loss, particularly among those with type 2 diabetes,” Professor Coundoulis said.
“We hope to show that Calca may also increase the body mass index, which is an indicator of weight gain and the risk of developing diabetes.”
Professor Coundouls research team have recently published results on the effect of Cala supplementation in adults, who have a low body mass and were overweight or obese.
The team has also examined the effects Cala on older adults and found that it reduced their risk of cardiovascular disease, as well as their risk for type 2 diabetics.
Professor Cinderlo, who was one of the lead researchers on the Calca study, said the research showed that Calcium was a “game changers” for the health of Australians.
“The findings suggest that a dietary supplement containing Cala is effective for reducing obesity rates, and is also potentially effective in preventing type 2 Diabetes, which affects around 7 per cent of Australians,” she said.
Professor Wrigglesworth said he was “very excited” about the new research, adding that Cala could be an “essential supplement” for Australia.
“This study suggests that Calc-a could have a key role in preventing the onset of type 2 Diabetic complications,” he said.
The University of Queensland also partnered with Calc to create a new study, to explore the effects on the body of Calc supplementation.
The researchers are currently studying Calca supplementation in children aged six to 15.
Professor Carole Coyle, Director of Research, said it was important to look at how Calca could be beneficial for Australia, as a nation with a growing obesity epidemic.
“In the last decade, we have seen an unprecedented increase in the number and size of obesity-related deaths in Australia, and the findings of this new study indicate that Calcas supplements are a viable option to reduce these deaths,” Professor Carole said.
Follow the Australian Medical Association’s obesity prevention campaign on Facebook